PGI/PGII Rapid Quantitative Test

Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.

PGI Rapid Quantitative Test

Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).

PGII Rapid Quantitative Test

FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay)

FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free triiodothyronine 3 (FT3) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

FLI-600 FIA Immunoassay Analyzer

FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free thyroxine 4 (FT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

Myo Rapid Quantitative Test

Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.

hscTnI Rapid Quantitative Test (Fluorescence Immunoassay)

The Biotime hscTnI (highly sensitive cardiac troponin I) Rapid Quantitative Test is intended to quantify the concentration of cTnI in human serum, plasma, or whole blood on Biotime FIA Analyzers(Semi-automatic / Automatic) by fluorescent immunoassay. It is used as an aid in the detection of myocardial Infarction. -Fluorescent immunoassay -Myocardial Infarction For in vitro diagnostic use only. For professional use only.

Specimen Types	Serum
Specimen Capacity	10μL
Reaction Time	15 min
Sample Capacity	80μL
Detection Range	Same as individual item

Fluorescence Immunoassay

Gastrointestinal Marker

PGI/PGII Rapid Quantitative Test